Suchergebnisse - "Kong, Liang"

PubPharm (20)

1

ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP/PS-1 mice

enthalten in: Drug development and industrial pharmacy | 2023

von Chen, M. | Liu, X. | Qu, X. | +8

2

Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer's disease-related symptoms in APP/PS-1 mice

enthalten in: Journal of drug targeting | 2023

von Zhang, X. | Shi, N. | Chen, M. | +6

3

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease

enthalten in: Drug delivery | 2022

von Wang, J. | Kong, L. | Guo, R. | +7

4

RNA interference-based osteoanabolic therapy for osteoporosis by a bone-formation surface targeting delivery system

enthalten in: Biochemical and biophysical research communications | 2022

von Gao, Y. | Xin, H. | Cai, B. | +6

5

Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy

enthalten in: Biomaterials science | 2022

von Guo, R. | Zhang, X. | Yan, D. | +7

6

The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice

enthalten in: Life sciences | 2021

von Zhang, L. | Kong, L. | He, S. | +5

7

Multifunctional osthole liposomes and brain targeting functionality with potential applications in a mouse model of Alzheimer's disease

enthalten in: Journal of liposome research | 2021

von Ni, Y. | Kong, L. | Li, X. | +12

8

Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis

enthalten in: Journal of liposome research | 2021

von Li, X. | Jing, M. | Cai, F. | +3

9

Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition

enthalten in: Journal of liposome research | 2021

von Cai, F. | Yao, X. | Jing, M. | +8

ErratumIn: J Liposome Res. 2022 Mar;32(1):104. - PMID 35129425

10

GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial-mesenchymal transition

enthalten in: Drug development and industrial pharmacy | 2020

von Yao, X. | Niu, F. | Kong, L. | +9